Global Metabolomics Services Market, by Service Type (Targeted Metabolomics Service, Untargeted Metabolomics Service), by Technique (Detection Techniques (Nuclear Magnetic Resonance Spectroscopy (NMR), Mass Spectrometry (MS)), Separation Techniques (Gas Chromatography (GC), Capillary Electrophoresis (CE), Liquid Chromatography (LC), Others (Supercritical Fluid Chromatography, Ion Mobility Spectrometry, etc.)), by Application (Drug Assessment, Biomarker Discovery, Nutrigenomics, Clinical toxicology, Others (Crop Breeding, Disease Diagnosis, etc.)), by End User (Academics and Research Labs, Biotechnology and Pharmaceutical Companies, and Diagnostic Laboratories), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 483.74 Million in 2022 and is expected to exhibit a CAGR of 14.2% during the forecast period (2022-2030), as highlighted in a new report published by Coherent Market Insights.
Increasing adoption of inorganic strategies such as acquisition by key market players is expected to drive the global metabolomics services market over the forecast period. For instance, In October 2022, Clinical Microbiomics, a microbiome research company, announced that it had acquired MS-Omics, a metabolomics provider. Under this acquisition, Clinical Microbiomics adds expertise in metabolite profiling from MS-Omics to further advance its systems biology platform and help researchers worldwide to understand microbiome and how it impacts health and disease.
Global Metabolomics Services Market– Impact of Coronavirus (COVID-19) Pandemic
The COVID-19 pandemic and consequent lockdowns in various countries across the globe have impacted the financial status of businesses across all sectors, including the private healthcare sector. The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry, mainly due to strict lockdowns in several regions. Private healthcare is one such sector that has been significantly impacted by the COVID-19 pandemic.
Many patients with COVID-19 have a severe respiratory infection that requires hospitalization and mechanical ventilation. Governments of various countries are focusing on initiatives to fight against the COVID-19 pandemic and stop the spread of the coronavirus infection by implementing various measures in the countries. Moreover, the governments of various countries have collaborated with universities around the globe to find novel treatments option for COVID-19 and its related complications.For instance, according to clinical trials, a government organization, in August 2021, Ministry of Health, Saudi Arabia have collaborated with Jilin University China, Albert Einstein College of Medicine, U.S., and Faculty of Science, Kafrelsheikh University, Egypt, to investigate the potential role of Aerosolized retinoic acid, a potent Vitamin-A metabolite for treating COVID-19 anosmia and retinoic acid insufficiency (novel approach for regaining Sense of Smell). Currently, the study is in phase IV of clinical trials.
Global Metabolomics Services Market: Key Developments
Adoption of inorganic strategies such as product launch by key market players is expected to drive the global metabolomics services market over the forecast period. For instance, in July 2021, Creative Proteomics, a biotechnology company, announced that they had launched new metabolomics division Creative Proteomics Metabolomics solutions which includes untargeted metabolomics services, targeted metabolomics services and untargeted lipidomics services, plant metabolomics services, and animal metabolomics services.
Browse 44 Market Data Tables and 36 Figures spread through 256 Pages and in-depth TOC on “Global Metabolomics Services Market”- Forecast to 2030, Global Metabolomics Services Market, by Service Type (Targeted Metabolomics Service, Untargeted Metabolomics Service), by Technique (Detection Techniques (Nuclear Magnetic Resonance Spectroscopy (NMR), Mass Spectrometry (MS)), Separation Techniques (Gas Chromatography (GC), Capillary Electrophoresis (CE), Liquid Chromatography (LC), Others (Supercritical Fluid Chromatography, Ion Mobility Spectrometry, etc.)), by Application (Drug Assessment, Biomarker Discovery, Nutrigenomics, Clinical toxicology, Others (Crop Breeding, Disease Diagnosis, etc.)), by End User (Academics and Research Labs, Biotechnology and Pharmaceutical Companies, and Diagnostic Laboratories), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
To know the latest trends and insights prevalent in this market, click the link below:
https://www.coherentmarketinsights.com/market-insight/metabolomics-market-180
Increasing adoption of inorganic strategies such as partnership by key market players is expected to drive the global metabolomics services market over the forecast period. For instance, in June 2021, BGI, a biotechnology company, announced that they entered into a partnership with Champions Oncology, a drug discovery and development company, to offer their respective customers end-to-end proteomics and multiomics solutions for oncology biomarker discovery and validation
Key Takeaways of the Global Metabolomics Services Market:
- The global metabolomics services market is expected to exhibit a CAGR of 14.2% during the forecast period, due to the increasing adoption of inorganic strategies such as product launch by key market players over the forecast period. For instance, in October 2021, Metabolon, Inc., a health technology company, announced that they had launched a new SmartPanel portfolio. SmartPanel solutions provide drug discovery and precision medicine researchers with a novel, dynamic process to explore biologically relevant views of metabolomic data in the context of specific metabolic pathways, biological themes, and disease associations.
- Among service type, untargeted metabolomics service segment is estimated to hold a dominant position in the global metabolomics services market over the forecast period due to the increasing product launch by key market players. For instance, in July 2020, Creative Proteomics, a biotechnology company, announced that they had launched untargeted metabolomics services to researchers for drug development. The service ranges include serum untargeted metabolomics, urine untargeted metabolomics, cerebrospinal fluid untargeted metabolomics and exosome untargeted metabolomics, which are based on some of the most powerful platforms and techniques in this field with unrivaled accuracy and sensitivity.
- Among regions, North America is estimated to account for the largest market share in the global metabolomics services market over the forecast period, owing to the increasing inorganic strategies such as partnership to expand its proprietary and innovative diagnostic services by key market players. For instance, in June 2020, Metabolomic Technologies Inc., a diagnostic technology company, announced that they had made a partnership with Forefront Health Partners, services, healthcare consulting group, and QualiTox Laboratories, LLC., a high complexity laboratory, to expand within the U.S. market by offering a convenient at home sample collection PolypD kit for urine testing.
- Major players operating in the global metabolomics services market include Thermo Fisher Scientific Inc., Agilent Technologies, Inc., SCIEX (Danaher), Waters Corporation, Shimadzu Corporation, Bruker, Human Metabolome Technologies Inc., LECO Corporation, Biocrates life sciences AG, Metabolon, Inc., Metabolomic Technologies Inc., PerkinElmer Inc., Analytik Jena GmbH, Creative Proteomics, Vproteomics, DNA Xperts Private Limited, MS-OMICS, metaSysX, BASF SE, BGI, Afekta Technologies Ltd., Metware Biotechnology Co.,Ltd.
